Outlook Therapeutics Names New CFO Ahead of LYTENAVA Launch
Outlook Therapeutics appointed Kevin Lundquist chief financial officer, treasurer, principal financial officer and principal accounting officer effective September 1. Lawrence A. Kenyon will leave those roles the same day, remain a non-executive employee through…
